Vicore Pharma Holding AB (publ) (VCRE)
NASDAQ: VCRE · Real-Time Price · USD
9.90
-0.22 (-2.17%)
At close: Nov 18, 2026, 4:00 PM EST
10.13
+0.23 (2.32%)
After-hours: Nov 18, 2026, 4:10 PM EST
Vicore Pharma Holding AB Market Cap
Vicore Pharma Holding AB has a market cap or net worth of $278.12 million as of November 18, 2026. Its market cap has decreased by 5.98% in one year.
Market Cap
278.12M
Enterprise Value
202.31M
1-Year Change
-5.98%
Global Rank
n/a
Country Rank
n/a
Category
ChartMarket Cap Chart
Since December 10, 2015, Vicore Pharma Holding AB's market cap has increased from $10.33M to $278.12M, an increase of 2,592.15%. That is a compound annual growth rate of 35.09%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 18, 2026 | 284.30M | -17.86% |
| Dec 30, 2025 | 346.13M | 92.86% |
| Dec 30, 2024 | 179.47M | 14.25% |
| Dec 29, 2023 | 157.08M | 11.76% |
| Dec 30, 2022 | 140.55M | 27.27% |
| Dec 30, 2021 | 110.43M | -52.45% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Autolus Therapeutics | 311.41M |
| Scribe Therapeutics | 309.82M |
| Galectin Therapeutics | 307.59M |
| Inhibikase Therapeutics | 305.27M |
| Agenus | 304.51M |
| PepGen | 301.97M |
| Century Therapeutics | 299.64M |
| Nautilus Biotechnology | 295.50M |